Screener
Nektar Therapeutics NKTR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's invested capital?
- Nektar Therapeutics (NKTR) reported invested capital of $653.68M in Q1 2026.
- How has Nektar Therapeutics's invested capital changed year-over-year?
- Nektar Therapeutics's invested capital increased by 511.2% year-over-year, from $106.95M to $653.68M.
- What is the long-term trend for Nektar Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Nektar Therapeutics's invested capital has grown at a -32.4% compound annual growth rate (CAGR), from $1.22B to $172.39M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Nektar Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude